Suppression of tumor immune microenvironment via microRNA‐1 after epidermal growth factor receptor‐tyrosine kinase inhibitor resistance acquirement in lung adenocarcinoma

Immunotherapy is considered one of the most important therapeutic strategies for patients with lung adenocarcinoma after the development of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR‐TKI) resistance. However, useful predictors of immunotherapy for these patients has not been ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawana, Sachiko, Saito, Ryoko, Miki, Yasuhiro, Kimura, Yuichiro, Abe, Jiro, Sato, Ikuro, Endo, Mareyuki, Sugawara, Shunichi, Sasano, Hironobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877390/
https://www.ncbi.nlm.nih.gov/pubmed/33305905
http://dx.doi.org/10.1002/cam4.3639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877390/
https://www.ncbi.nlm.nih.gov/pubmed/33305905
http://dx.doi.org/10.1002/cam4.3639

Ejemplares similares